Volume: Volume 74 Publisher: Elsevier: 12 months | 2018-11-01, Pages 88-96 Abstract Many adolescents with sickle cell disease (SCD) experience recurrent and chronic pain, which has a negative impact on their health-related quality of life (HRQL). Cognitive-behavioral therapy (CBT) interventions can lead to improvement in pain and HRQL, yet due to barriers to care, most youth with SCD will not receive these interventions. To address this need for innovative programs targeting youth with SCD pain, we developed iCanCope, a tailored smartphone and web-based program that delivers a pain self-management intervention to youth with SCD. We describe the rationale, design, and implementation of a three-site parallel group randomized controlled trial with a sample of 160 adolescents with SCD and their parent caregivers. The iCanCope program includes pain self-management skills training (personalized CBT-based coping skills such as deep breathing, relaxation, and cognitive skills), goal setting, and social support. The attention control group is provided with access to a self-guided website with education about SCD. Assessments will occur at baseline (T 1 ), immediately after completion of the intervention (12 weeks; T 2 ) and at 6 months post-intervention (T 3 ). Primary outcomes include coping strategies and pain intensity; secondary outcomes include physical, social, and emotional functioning, treatment satisfaction, health service use and caregiver response to youth pain behavior. Potential mediators (goal setting, self-management, and perceptions of social support) and moderators (e.g., demographic factors) will also be tested. The objective is to offer an effective, convenient, and low-cost psychosocial intervention to youth with SCD to enhance their self-management of pain.
Introduction
Sickle cell disease (SCD) is the most common genetic blood disease among individualsin North America, most often occurring in individuals of African descent (1) . Although episodic acute pain is recognized as the hallmark of this disorder, there is increasing awareness that many individuals experience chronic SCD pain (2) . Painful crises are the main reason for SCD-related hospitalization (3) , and drive annual healthcare costs of $1.1 billion (4) . Similar to other pediatric chronic pain conditions, youth with frequent SCD pain experience negative impact on all aspects of health-related quality of life (HRQL) (5) (6) (7) including pain-related functional disability and depressive symptoms (7, 8) . Pain becomes more frequent in older adolescence, and by adulthood, almost 30% of patients report daily pain (9) .
Although opioid therapy is the most relied upon approach to pain management in SCD, evidence indicates that opioid therapy does not provide adequate pain relief and that its longterm use leads to negative physical and psychological consequences and stigma (10) . As such, there is a pressing need for effective, non-pharmacologic interventions to treat chronic pain in patients with SCD.
Cognitive behavioral therapy (CBT) to promote pain self-management can lead to pain reduction, improved coping skills and HRQL, and decreased healthcare use for youth with a range of chronic pain conditions (11) (12) (13) . However, evidence for the efficacy of psychological therapies in SCD is currently fairly limited (14) due to the small number of studies conducted and very small sample sizes enrolled. A major barrier in implementing CBT in SCD populations is that it is challenging to deliver pain management interventions in traditional office-based visits (15) , and investigators have described the critical need to improve feasibility of psychosocial interventions for pediatric SCD pain (16) . The use of Internet-and smartphone-delivered interventions is a potential option to overcome barriers to accessing pain management services for youth with SCD and their families. Evidence from a systematic review showed that treatments delivered on the Internet reduce pain and disability in youth with other types of chronic pain (17) . In addition, access to Internet and smartphone technologies among African Americans is high (80-85%) (18) , even among those of low income (19) .
Two prior technology-based interventions have been evaluated in youth with SCD pain (20) . In the first study, a sample of children and adolescents with SCD were provided with one inperson session of CBT followed by 8 weeks of home-based practice using a smartphone, with weekly clinician phone contact. In comparison to the waitlist control, participants who received CBT believed they had more control over their pain, but had no change in their negative thinking in response to pain or in their pain intensity. The smartphone application was underutilized (average use of only 12% over the 8-weeks), and the coping skills section of the application was accessed on less than a quarter of the total pain days reported by all youth. However, in the second study, an Internet-delivered CBT program for pain management was piloted with youth in a small randomized controlled trial (RCT), finding that it was feasible to deliver and acceptable to adolescents with SCD and their caregivers and that engagement and adherence were good (21) .
Objectives
Our goal is to improve pain self-management and functioning in youth (aged 12-18 years) with SCD by developing and testing a tailored web and smartphone-based application (iCanCope with SC Pain). We aim to evaluate, in a three-site RCT, the efficacy of the intervention with a sample of 160 adolescents with SCD and their parent caregivers. We will also examine mediators and moderators of treatment effects to enhance understanding of who benefits from the intervention and what mechanisms underlie benefit from the pain selfmanagement intervention. The objective is to offer an effective, convenient, and low-cost psychosocial intervention to youth with SCD to enhance their self-management of pain.
Aims and Hypotheses Aim 1.
To determine feasibility and initial efficacy of iCanCope in youth with SCD pain. We hypothesize that youth who receive iCanCope will achieve significant increases in adaptive coping and reductions in pain (primary outcomes) as well as significant improvements in physical and emotional functioning and disease-specific health-related quality of life (secondary outcomes) at post-treatment and 6-month follow-up compared to youth who receive an attention-control condition. Feasibility and acceptability will be demonstrated by high levels of treatment engagement and high ratings of satisfaction with the intervention.
Aim 2.
To examine possible mediators of the effects of iCanCope to test the hypothesis that changes at post-treatment in youth goal setting, self-efficacy, self-management, and perceptions of social support mediate intervention effects on youth pain intensity, pain-related disability, and adaptive pain coping at 6-months.
Aim 3.
To examine possible moderators of effects of iCanCope through exploratory analyses.
Potential moderators will include: engagement with treatment, demographic factors (family income, child age, gender), executive function skills, and disease characteristics (SCD pain burden).
Study Design
This is a parallel group, single blinded randomized controlled trial with stratified randomization based on age and treatment center to intervention vs. active control conditions. The intervention phase will last 12 weeks. Outcome assessment will occur at baseline (T 1 ), immediately after completion of the intervention (12 weeks, T 2 ) and be repeated at 6 months post-intervention (T 3 ). The T 3 assessment will capture potential maintenance of treatment gains as youth with SCD may have fluctuations in their disease course that influence pain outcomes.
Participant Eligibility, Recruitment, Enrollment, and Randomization
Youth will be eligible if they: (a) are aged between 12-18 years, (b) are diagnosed with SCD, (c) are able to speak and read English, (d) score at least 4 (indicating some days with pain interference over the past month) on the Sickle Cell Pain Burden Interview (22) and (e) are willing and able to complete online measures. Parent caregivers will be eligible if they: (a) are able to speak and read English and (b) are willing and able to complete online measures. Youth will be excluded if they have significant cognitive limitations that would impair their ability to use and understand the iCanCope program, as per their healthcare provider or parent. Youth will also be excluded if they have received more than 4 sessions of outpatient psychological therapy for pain management in the 6 months prior to the time of screening.
Participants will be recruited from three pediatric centers: Connecticut Children's Medical Center, Children's Healthcare of Atlanta/Emory University, and The Hospital for Sick Children in Toronto. Patients listed on the participating clinic registries will be screened for eligibility by the local study investigator. Initial patient contact will be made either through a mailed letter or in-person during scheduled clinic visits. If youth are interested in learning more, study staff will explain the study and seek informed consent or assent. Research staff will track the number of eligible youth approached and reasons for refusal. After obtaining informed consent, study staff at the Seattle site will send out pre-treatment measures to complete online via REDCap. Following completion of pre-treatment measures, participants will be randomized to an intervention condition. Participants will be instructed on the procedures to be followed within the intervention and control groups using standardized manuals. See Figure 1 for study flow.
Participants will be randomly allocated using a hidden allocation scheme to either the CBT intervention (iCanCope) or attention control education group. Randomization will be centrally controlled at the Seattle site and will be stratified by study center (i.e., to control for site-specific disease education and treatment approaches) and age (i.e., to control for developmental stage; 12-14 years and 15-18 years). The randomization schedule will be created by the study data manager who is not involved in participant recruitment or intervention assignment. The randomization schedule will be stored in a password-protected document accessible only to study staff involved in intervention assignment.
Description of study Arms
CBT intervention group.-iCanCope includes components from prior pain management interventions. The web based skills and education content is adapted from an Internetdelivered cognitive-behavioral therapy (CBT) pain intervention for teens with general chronic pain conditions that resulted in significant reduction in activity limitations from baseline to 6-month follow-up compared with Internet education. This intervention was piloted in 12 youth with SCD and their parents recruited from two of the sites for this trial (21) . Treatment engagement was high for both adolescents and parents. In qualitative interviews, participants reported the CBT program was a helpful tool for coping with pain and indicated a preference for a web program that was designed specifically for youth with SCD.
The iCanCope app platform was initially developed for youth with chronic pain and adapted for this trial for youth with SCD. For more information on the development of the chronic pain platform see (23) . Five patient partners with SCD were involved in adapting the platform and content specifically for SCD. The patient partners used the chronic pain platform and provided advice on how to adapt it to SCD. Changes included making the content shorter and more concise, creating video content which includes youth with SCD, and adapting the example scenarios in the content to be more relevant to the population.
In addition to standard care, youth will receive the iCanCope intervention over a period of 12 weeks. The iCanCope program includes (i) pain self-management skills training, (ii) goal setting, and (iii) social support. See screenshots of the app in Figure 1 . The program is designed to enhance self-efficacy. Participants will be encouraged to set SMART (Specific, Measurable, Achievable, Results-focused, and Time-bound) goals. The pain selfmanagement skills include personalized CBT-based coping skills including deep breathing, relaxation, and cognitive skills (e.g., staying positive). The app is developed natively for iOS and Android smartphones while the website is accessible on all modern web browsers. The program is restricted to study participants. Detailed user level and aggregate analytics will be captured to track user engagement.
The app has four key features (see Figure 2 ): daily symptom tracking, goal setting, selfmanagement skill library, and social community. The daily check-in feature uses adolescentfriendly language and pictorial response options to optimize participant engagement. Pain intensity is self-reported on a 0-10 numerical rating scale with the anchors, "no pain" and "worst pain". Other symptom categories (pain impact, mood, and sleep quality) are captured via individual 5-point scales where a lower score indicates better function. Participants will receive daily push notification check-in reminders at a time of their choice and be able to view their historical check-in data at any time within the app. The goals feature is designed to support participants in setting and tracking personalized goals to improve their function. Participants can design their own goals or adapt suggested goals within the categories of activity, sleep, and mood. The skills library provides in-the-moment access to pain coping strategies to promote positive changes in mood, behavior, and pain. The library consists of curated articles relevant to different aspects of living with and managing SCD pain. Tailored articles are suggested to participants based on their check-in data (e.g. "developing a winddown routine" article if participant reports poor sleep quality). The social community is a structured forum where participants can interact with other young people living with SCD pain. Each week, the app poses a new question for discussion, such as, "What's your favorite distraction from pain?" Participants can post responses to each community question and also "favorite" the posts of other app users.
Youth and their caregiver will also be encouraged to access the iCanCope website, which contains interactive SCD education and self-management strategies. The website is organized into 6 core modules and 2 additional optional modules, which will be assigned Palermo 
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Author Manuscript based on individual screening measures for depressive symptoms and insomnia. The website uses a multimedia-rich format (e.g., animations, videos, audio clips) to deliver content. Content is: (a) written at a grade 5-6 reading level, (b) developmentally appropriate for the full age range of youth participants [12-18 years] , and (c) culturally relevant.
Participants will be instructed to complete one website module per week over the study period. Each module closes with an assignment for the participant to practice the skills taught that week.
Caregivers have access to a website that includes behavioral plans, problem-solving skills, and communication strategies intended to provide instruction in the best ways to support their child's pain management skills and encourage adaptive coping. The same usage information is collected for the caregiver website. Table 1 provides a summary of the website module content for youth and parent caregivers. Weekly reminders (e.g., text, call, email) will be sent to participants and parents to encourage use of the app and website.
Attention control education group.-The comparator group is designed to account for potential effects on outcomes of time, attention, as well as computer use during the intervention period. In addition to standard medical care, youth and parent caregivers in the attention control group will be provided with access to a self-guided education study website, which will contain static education about SCD (no self-management skills, goalsetting, or social support content). Table 2 provides a summary of the website module content for youth and parent caregivers. The control condition will be delivered over 12 weeks on the same password-protected web-based platform as the intervention group website that will allow us to track usage and engagement. Participants will be encouraged to log onto the control website (i.e., email reminders) and complete all study outcome assessments online at the same time intervals as the experimental group. Program usage data will also be collected for participants in the attention control group.
Study Monitoring Procedures
Treatment fidelity.-Treatment fidelity for both interventions will be assessed in several ways. The administrative interface of the iCanCope application and website will have tracking systems for recording each time a user logs onto the web program, and thus, amount of app and web site usage will be recorded. Assignments and use of different skills will also be recorded.
In order to ensure fidelity to the protocol across sites, study procedures are centrally managed using email and phone by one site for all participants. The Seattle site will conduct all study assessments, randomization, and participant onboarding into the allocated treatment group. We will conduct monthly phone calls across sites to review study management.
Measures.
Outcomes will be assessed across the two intervention groups at T1= pre-treatment; T2 = post-treatment (12 weeks); T3 = follow-up (6 months post-treatment). All measures will be completed online via REDCap. Table 3 provides details on study measures.
Primary outcome measures.-We have two primary outcomes, coping strategies and pain. To assess use of strategies to cope with pain, adolescents will complete the Coping Skills Questionnaire (CSQ) (24) . The CSQ is an 80-item questionnaire with three primary scales: Coping Attempts, Negative Thinking, and Passive Adherence. The CSQ has demonstrated adequate reliability and validity in pediatric sickle cell disease [31] . To assess pain, adolescents will complete daily pain diaries for 7 days at each measurement period and report pain intensity using an 11-point numerical rating scale (NRS; 0 = no pain, 10 = worst pain possible). The NRS is a widely used measure of pain intensity in adolescents and demonstrates good reliability and validity (25) . Screening and background measures.-Participants will complete three screening measures. The Sickle Cell Pain Burden Interview (SCPBI) (22) will be used to screen for SCD pain burden in the past month in six domains. Youth will complete two items from the Adolescent Sleep Wake Scale (ASWS) (34) to screen for insomnia symptoms in order to deliver optional insomnia content in the iCanCope program. Youth will complete the depressive symptoms scale from the PROMIS Profile [36] in order to deliver optional depression content.
Participants will rate treatment expectancies with a measure adapted for the current study, the Treatment Expectancy Questionnaire (TEQ) (35) , which asks respondents to rate how likelyit is that "a sickle cell pain program" will be useful and helpful. Participants will also report on sociodemographic variables (e.g., family income), internet and computer use, and comfort with technology.
Process measures.-Process measures include iCanCope program usage; the
Multidimensional Scale of Perceived Social Support (MSPSS) (36) to assess social support from family, friends, and significant others; the Patient Activation Measure (PAM) (37) to assess the ability to self-manage illness; the Sickle Cell Self-Efficacy Scale (SCES) (38) to assess disease-specific perceptions of self-efficacy; and the Behavior Rating Inventory of Executive Function -Parent Form (39) to assess frequency of youth problem behaviors associated with executive function.
Adverse events.-Adverse events will be collected at post-treatment and follow-up using a child and parent self-report scale developed for this study.
Retention and Adherence
We will over-recruit by 20% to account for potential dropouts and loss to follow-up. An intent-to-treat approach will be used for the analysis. However, every effort will be made to maintain participation in the study groups and to obtain post-treatment measures on all participants. Participants will receive a gift card for each outcome assessment completed (T 1-3 ). We will ask for multiple phone numbers, which will aid in follow-up. We will use emails and text messages to remind participants of the various online assessments. Every effort will be made to maintain participation in the study groups and to obtain post-treatment measures on all participants who are enrolled in the study.
Strategies for dealing with nonadherence will include: designing an appealing and engaging program as per user-centered methodology, gamification elements (e.g., positive feedback loops, short-term and meta goals), and social elements (e.g., peer support). Characteristics of adherent versus non-adherent youth will be examined for systematic differences. When found, sensitivity analyses will determine effect on outcomes.
Sample Size and Power Estimations.
Based on our prior and current study experience, and the pool of available study candidates, we are expecting to enroll a total of 160 subjects into the RCT. With attrition conservatively estimated at 20% we expect a final sample size of 128. Based on preliminary data from our prior trials and other published trials in SCD, power estimates are based on expected differences in pain intensity. Group sample sizes of 49 and 49 achieve 80% power to detect a difference of 0.75 in pain intensity (average over three time points) in a design with 3 repeated measurements having an autoregressive (1) covariance structure, SD=2, ICC=0.2 and 0.05 alpha.
Data Analysis
Distributions of primary and secondary outcome variables at each time point (and on difference scores between time points) will be examined first with summary statistics and graphical tools. For outcome variables with highly skewed distributions, we will either apply transformation or non-parametric test procedures. Preliminary work will also involve computation of scale reliabilities (e.g., internal consistency using Cronbach's alpha) of all of the self-report measures. The analysis will be an intent-to-treat analysis including all randomized subjects.
Analytic Plan for Aim 1: Feasibility will be determined by calculating rates of accrual, drop out, compliance, and missing data with 95% CI's. Criteria for feasibility success will be based on previous studies by our group: accrual rates >70%, attrition rates <20%, minimal technical difficulties (i.e., reported by <10%), high acceptability and satisfaction (score > 27 on TEI), adherence rates >80% (adherence operationalized as completion of at least 50% of the intervention (i.e., 3 of 6 intervention web modules as well as a completed app check-in on 28 of 56 days), and minimal missed responses. In Aim 1, we will also determine preliminary efficacy of the intervention. To account for clustering due to repeated assessments within individuals, we will use generalized estimating equations (GEE). Interaction terms will be used to compare the mean change from pre-treatment to posttreatment for the CBT intervention group with the corresponding mean change for the Attention Control Education group. Single degree of freedom contrasts will test if there is a statistically significant change in pain and coping from pre-treatment to immediate posttreatment for the two groups separately; additional contrasts will be computed to test if there is a statistically significant mean change from baseline to the 6-month follow-up for each group. Secondary treatment outcomes (physical and emotional function, HRQL) will also be examined using GEE to test significant mean changes over time and between groups by using interaction terms and contrasts. Treatment fidelity will be assessed by examining differential attrition (completers vs. non-completers) between and within groups using chisquared tests and logistic regression models.
Analytic Plan for Aim 2 and 3: Our working hypothesis related to Specific Aim 2 is that differences in self-efficacy, self-management behaviors, and perceived social support will predict changes in pain intensity and coping strategies in youth with SCD. The test of this hypothesis will follow the recommendations for testing "moderated mediation" models described by Bauer (40) , which permits specification of a single equation that furnishes the coefficients necessary for estimating total, direct, and indirect effects in a multilevel mediation model. The single equation is made possible by creating a new outcome variable ("Z") that comprises both the outcome variable of interest ("Y") and mediating variable ("M") simultaneously; the two are distinguished by creating two specification variables ("S") that take on the value of 0 and 1 depending on whether the new outcome variable "Z" represents the mediating variable or outcome variable. The models will be specified with "time" as a predictor ("X") of the outcomes pain intensity and coping strategies, with the self-efficacy, self-management behaviors, and perceived social support variables included as mediating variables ("M"). The indirect effect of time will then be specified to be predicted by treatment. As such, this model will allow a test of whether an individual's changes over time in pain outcomes are partly explained by changes in the hypothesized mediators and whether the strength of this indirect effect varies depending on group.
We will use exploratory analysis to examine possible moderators of effects of iCanCope including engagement with treatment, demographic factors (family income, age, sex), executive function, and disease characteristics (SCD pain burden). To assess the moderation effect we will include an interaction term for each separate moderator variable and key predictor of interest (two-way interaction between moderator and group for cross-sectional analysis and three-way interaction between moderator, group and time for longitudinal analysis) in the regression models and test its significance using Wald t-test.
Discussion
The unique contributions of the proposed research include: (a) establishing the extent to which iCanCope is an efficacious and viable means of disseminating evidence-based pain self-management therapy for youth with SCD; (b) determining the potential impact of this intervention on key health outcomes and processes (e.g., pain, HRQL, and pain coping strategies) that are not optimally addressed with medical treatment alone; (c) conducting the first RCT to evaluate an integrated web-and mobile-based pain self-management app in youth with SCD; (d) optimizing program value by actively engaging youth with SCD and their families through a user-centered design approach to development and evaluation (41) ; and (e) testing mediators and moderators of treatment effects to begin to understand who benefits from the intervention and through what processes.
A number of barriers can be addressed through using digital technologies to deliver treatment. Specifically, we are able to address the geographic restrictions to CBT pain services, the limited availability of clinicians trained in CBT for SCD pain, the direct and indirect incurred costs of additional healthcare visits to receive CBT (42, 43) , and the stigma associated with seeking assistance through mental health services (44) .
Several aspects of the intervention and study design are novel. A major strength of our approach to developing the intervention is applying user-centered design principles in order to maximize patient engagement. We have actively engaged youth with SCD ("patient partners") throughout the process of developing iCanCope with SC Pain. These patient partners have formed a youth advisory panel that provides feedback and guidance. We have facilitated interactive design sessions with the web and app development teams from AboutKidsHealth and eHealth Innovation at the University Health Network and our patient partners from the USA and Canada. These sessions adhere to the principles of human factor design and enabled further definition of user requirements for the app and website (41) . This patient engagement has also identified ways that iCanCope with SC Pain can be designed to fit into the daily lives of our target users, which is critical for maximizing engagement and ensuring cultural and linguistic appropriateness (45) . While a user-centered design approach has been successfully applied to develop apps for individuals with chronic illnesses such as diabetes (45) and asthma (41) , to our knowledge, it has never been used for SCD.
We recognize the significant difficulty in previous SCD clinical trials with obtaining adequate recruitment and retention where prior trials have reported rates of recruitment as low as 13% of available samples (15, 20, 46) . Because one of the key barriers to participation in intervention studies by patients with SCD is reaching them by phone and scheduling study visits (21) , we have devised multiple strategies for reaching youth and families such as through text and email. Moreover, others have noted the significant challenges of enrolling African-American youth and their parents into intervention research where broader issues such as socioeconomic barriers, mistrust and misunderstanding of research (47) , and lack of perceived benefits from research participation may contribute to low enrollment (16) . Our use of patient engagement strategies throughout the research process is expected to address some of these participation barriers. In addition, by using an active comparator as opposed to a no treatment control condition we believe the value of research participation to the individual is enhanced.
The results of this trial will have important implications not just for SCD behavioral interventions, but also for other pain self-management interventions more broadly. The knowledge contributions of the proposed research include evaluating an integrated web-and mobile-based pain self-management app in youth and testing mediators and moderators of treatment effects to begin to understand who benefits from the intervention and through what processes. In addition, this intervention represents a cost-effective alternative to traditional CBT that has the potential for widespread dissemination that may inform pain selfmanagement in multiple populations.
Conclusions
This study will evaluate whether a tailored smartphone and web-based application (iCanCope) improves pain self-management and functioning in youth (aged 12-18 years) with SCD. Because SCD morbidity and mortality increase markedly during adolescence and young adulthood (1), intervening during adolescence provides an important opportunity to help youth develop critical pain self-management skills to better cope with SCD pain as adults. Overall, we envision that iCanCope will address an important service gap by delivering pain self-management therapy that is highly appealing, accessible, and engaging to youth. If successful, the iCanCope intervention has the potential for national dissemination in the USA and Canada, via either self-referral or referral from pediatric hematologists. 
